STOCK TITAN

NeuroPace to Participate in Upcoming Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) announced participation in three significant healthcare conferences. The schedule includes:

  • Wells Fargo Virtual Healthcare Conference on September 10, 2021, at 9:20 a.m. ET.
  • Morgan Stanley Global Healthcare Conference on September 14, 2021, at 3:30 p.m. ET.
  • Baird Global Healthcare Conference on September 15, 2021, at 2:35 p.m. ET.

Live audio will be available on the company’s website, with archives accessible for at least 90 days post-event.

Positive
  • None.
Negative
  • None.

MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported that the company will be participating in three upcoming conferences.

  • 2021 Wells Fargo Virtual Healthcare Conference
    Fireside Chat on Friday, September 10, 2021, at 9:20 a.m. Eastern Time / 6:20 a.m. Pacific Time.
  • 19th Annual Morgan Stanley Global Healthcare Conference
    Fireside Chat on Tuesday, September 14, 2021, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.
  • 2021 Baird Global Healthcare Conference
    Presentation on Wednesday, September 15, 2021, at 2:35 pm Eastern Time / 11:35 am Pacific Time.

Live audio of the webcasts of the presentations will be available on the “Investors” section of the company’s website at: https://www.neuropace.com. The webcasts will be archived and available for replay for at least 90 days after the event.

About NeuroPace, Inc.

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Gilmartin Group
Matt Bacso, CFA
investors@neuropace.com


FAQ

What conferences is NeuroPace participating in September 2021?

NeuroPace will participate in the Wells Fargo Virtual Healthcare Conference on September 10, 2021, the Morgan Stanley Global Healthcare Conference on September 14, 2021, and the Baird Global Healthcare Conference on September 15, 2021.

When is the Wells Fargo Virtual Healthcare Conference?

The Wells Fargo Virtual Healthcare Conference is scheduled for September 10, 2021, at 9:20 a.m. Eastern Time.

What time is the Morgan Stanley Global Healthcare Conference?

The Morgan Stanley Global Healthcare Conference will take place on September 14, 2021, at 3:30 p.m. Eastern Time.

When will NeuroPace present at the Baird Global Healthcare Conference?

NeuroPace is set to present at the Baird Global Healthcare Conference on September 15, 2021, at 2:35 p.m. Eastern Time.

Where can I access the webcasts for NeuroPace's conference presentations?

The live audio of the webcasts will be available in the 'Investors' section of NeuroPace's website.

Neuropace, Inc.

NASDAQ:NPCE

NPCE Rankings

NPCE Latest News

NPCE Stock Data

182.77M
29.20M
4.19%
83.53%
1.74%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MOUNTAIN VIEW